Perrigo, Synthon Get Approval for Generic Xyzal

Perrigo Monday announced that its licensor and supplier Synthon has received final approval from the U.S. Food and Drug Administration for Levocetirizine tablets, a generic version of Xyzal tablets from UCB/Sepracor, marketed in the U.S. by Sanofi-Aventis.
Sacramento Bee